Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-50322

Single-particle
3.09 Å
EMD-50322
3D View Gallery
Deposition: 16/05/2024
Map released: 12/02/2025
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50322
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9fcv summary report (pdf.gz) Map and 9fcv FULL report (pdf.gz)
EMICSS annotations (xml)

Cas nuclease-CRISPR (cr)RNA ribonucleoprotein (RNP) complex

EMD-50322

Single-particle
3.09 Å
EMD-50322
3D View Gallery
Deposition: 16/05/2024
Map released: 12/02/2025
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Segatella buccae, synthetic construct
Sample: Cas13b (cr)RNA complex
Fitted models: 9fcv

Deposition Authors: Schmelz S, Lukat P, Blankenfeldt W
AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack.
Wandera KG, Schmelz S, Migur A, Kibe A, Lukat P, Achmedov T, Caliskan N, Blankenfeldt W, Beisel CL
(2025) Mol Cell , 85 , 1162
PUBMED: 39965569
DOI: doi:10.1016/j.molcel.2025.01.020
ISSN: 1097-2765
ASTM: MOCEFL
Grant Support: